A1440012
BCTC , 98% , 393514-24-4
Synonym(s):
4-(3-Chloro-2-pyridinyl)-N-[4-(1,1-dimethylethyl)phenyl]-1-piperazinecarboxamide
CAS NO.:393514-24-4
Empirical Formula: C20H25ClN4O
Molecular Weight: 372.89
MDL number: MFCD08690556
Pack Size | Price | Stock | Quantity |
10MG | RMB429.60 | In Stock |
|
50MG | RMB1759.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 150-152℃ |
Boiling point: | 561.6±50.0 °C(Predicted) |
Density | 1.229±0.06 g/cm3(Predicted) |
storage temp. | Sealed in dry,Room Temperature |
solubility | DMSO: >10mg/mL |
pka | 13.95±0.70(Predicted) |
form | powder |
color | white to beige |
Sensitive | Light Sensitive |
Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stord at -20°C for up to 2 months. |
InChIKey | ROGUAPYLUCHQGK-UHFFFAOYSA-N |
Description and Uses
BCTC (393514-24-4) is a vanilloid receptor I (TRPV1) blocker, IC50 = 35 nM for capsaicin-induced and 6 nM for acid-induced TRPV1 activation. Displays analgesic activity in rat models of neuropathic pain. BCTC is orally active and cell permeable.
BCTC is a antagonists of TRPA1 and TRPV1, a non-selective cation channel gated by noxious heat, vanilloids and extracellular protons. BCTC inhibits both capsaicin and proton activation.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P264b-P270-P301+P312-P330-P403-P501c |
Hazard Codes | Xn |
Risk Statements | 22 |
WGK Germany | 3 |